Who Owns GSK?

GSK plc — Institutional Ownership & 13F Holdings

$54.41

-0.03 (-0.06%)

Market Cap

$111.3B

Shares Outstanding

2,012,831,939

Institutional Holders

839

Total Inst. Value

$1.0T

% of Float Held

QoQ Holder Change

+240

Institutional data as of Q1 2025

New Positions

220

Closed Positions

74

Increased

275

Decreased

232

Institutional Ownership Trend

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
1PRIMECAP MANAGEMENT CO/CA/$995.9B25,708,020
2DODGE & COX$3.0B78,651,833
3FMR LLC$2.3B60,120,517
4Fisher Asset Management, LLC$1.2B30,031,815
5JTC Employer Solutions Trustee LtdNew$591.6M15,260,368
6GOLDMAN SACHS GROUP INC$420.8M10,862,887
7UBS Group AG$305.0M7,872,055
8PRICE T ROWE ASSOCIATES INC /MD/$299.2M7,722,314
9ROYAL BANK OF CANADA$293.7M7,581,079
10STATE STREET CORP$272.9M6,972,998

Biggest Buyers & Sellers This Quarter

Top Buyers

FundShares AddedValue
PRIMECAP MANAGEMENT CO/CA/+446K$995.9B
DODGE & COX+10.2M$3.0B
FMR LLC+7.3M$2.3B
Fisher Asset Management, LLC+11.2M$1.2B
JTC Employer Solutions Trustee LtdNew+15.3M$591.6M

Top Sellers

Famous Fund Managers

Related Stocks

Frequently Asked Questions

How many institutional investors hold GSK?

As of Q1 2025, 839 institutional investors report holding GSK (GSK plc) in their 13F filings.

Which hedge fund owns the most GSK?

The largest institutional holder of GSK is PRIMECAP MANAGEMENT CO/CA/ with $995.9B in shares.

Are institutions buying or selling GSK?

This quarter, 220 institutions opened new positions in GSK and 74 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.